DAIC

JULY 18, 2024

HeartFlow’s Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. F.A.C.C. “The

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Medicare 111

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

MARCH 27, 2024

a leader in AI-driven healthcare technology, announced the launch of the DECIDE Registry, the largest prospective registry of its kind, with the first site initiated, Cone Health Care. Coronary artery disease remains one of the leading causes of death in the United States.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

DAIC

FEBRUARY 26, 2025

a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. References Centers for Disease Control and Prevention. Heart Disease Facts.

Coronary Artery Disease 59

Coronary Artery Disease Heart Attack Heart attacks Technology 59

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

MAY 23, 2024

REVEALPLAQUE aimed to evaluate HeartFlow’s non-invasive plaque technology , an automated, deep learning-based method for identifying, characterizing, and segmenting plaque in the coronary arteries. 1 Heart disease is the leading cause of death for both men and women.² co-principal investigator and and K.

Plaque 52

Plaque Coronary Artery Disease Technology Anatomy 52

DAIC

OCTOBER 29, 2024

The investigators shared the first randomized controlled trial (RCT) of FFRangio outcomes compared to invasive wire-based fractional flow reserve (FFR) has met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive FFRangio technology over traditional wire-based approaches.

Technology 52

Technology Physiology Coronary Artery Disease Hospital 52